Microencapsulation with carrageenan-locust bean gum mixture in a multiphase emulsification technique for sustained drug release.
A multiphase emulsification technique was modified in this process of micro-encapsulating gentamicin sulphate, thus avoiding the necessity for a surfactant in preparing the secondary emulsion for a W/O/W emulsion. Various proportions of iota-carrageenan (i-C) and locus bean gum (LBG) were investigated for the W/O/W emulsion after forming the primary W/O emulsion with sorbitan trioleate, Span 85. Upon removal of the oil phase (chloroform) from the W/O/W emulsion by heating (60-65 degrees C), microcapsules or 'W/W' particles containing drug dissolved in sodium hyaluronate were spontaneously formed. These were dispersed in a solution of a mixture of 5-10 per cent w/v polyvinyl alcohol, PVA (average MW 50,000-106,000; 98 per cent hydrolysed) and 3 per cent v/v polyethylene glycol 200 (PEG 200), and dried to form the hydrogel film casts. Our in vitro experiments in isotonic phosphate buffer solution (pH 7.4) at 37 degrees C, showed that the release of gentamicin sulphate was dependent on concentration of LBG, and concentration or molecular weight of PVA. With the exception of PVA hydrogel matrix preparations containing 20 per cent w/v LBG, all other formulations showed a significant initial 'burst' release of drug within 6 h. The drug-containing microcapsules in the PVA hydrogel film with 20 per cent w/v LBG, exhibited an almost zero-order release of drug up to 140 h. It is postulated that an effective barrier or high-density membrane enveloping the microcapsules was formed between i-C and LBG because of their unique molecular configurations. This phenomenon, together with the possible adsorption of i-C molecules at the transient oil and outer aqueous phase interface, presumably eliminated the need for a permanent oil phase and/or an O/W surfactant normally required for preparing W/O/W emulsions.
Suzuki
S
S
Department of Ophthalmology, School of Medicine, West Virginia University, Morgantown 26505.
Lim
J K
JK
D001672:Biocompatible Materials / Q000737:chemistry; D002351:Carrageenan / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D004655:Emulsions; D005685:Galactans; D005839:Gentamicins / Q000008:administration & dosage* / Q000737:chemistry; D008351:Mannans; D053149:Plant Gums; D011134:Polysaccharides / Q000737:chemistry*; D011142:Polyvinyl Alcohol / Q000737:chemistry
D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D004655:Emulsions; D005685:Galactans; D005839:Gentamicins; D008351:Mannans; D053149:Plant Gums; D011134:Polysaccharides; D002351:Carrageenan; D011142:Polyvinyl Alcohol; C017471:locust bean gum